San Diego, CA – Artemis Institute for Clinical Research, a leader in Principal Investigator and Patient Focused clinical research, is pleased to announce the opening of a new facility in Riverside, California. The new facility will be utilized to conduct studies for Psychiatry/Neurology, Internal Medicine and Women’s Health indications.
“The addition of a site in Riverside significantly increases our clinical research capabilities,” said Rob Rifkin, Director of Business Operations. “We will now have 3,750 square feet of space and the ability to accommodate over 20,000 incremental clinical research study visits annually. We launched this site with a significant footprint to ensure we can serve as many patients as possible in Riverside and the surrounding communities.”
“Our vision for Artemis is to expand to new sites on the West Coast and beyond,” added Dr. Vishaal Mehra, CEO of Artemis Institute for Clinical Research. “Our new Riverside location has highly experienced Principal investigators and research staff dedicated to this site. We believe we can attract a large diverse pool of study participants, while continuing to deliver the high-quality data our sponsors have come to expect from us.”
Artemis Research has partnered with local vendors to enhance the ability to conduct a variety of research studies at this third location. The facility is centrally located in Riverside at the corner of Magnolia Street and the 91 freeway.
